← SynDRA
T-1095
SynDRA canonical compound SYN1204913 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | SLC5A2 |
| Mechanism of action | sodium/glucose cotransporter inhibitor |
All known targets
Mechanisms of action (all sources)
- sodium/glucose cotransporter inhibitor
- SLC5A1 MODULATOR
Cross-references
Synonyms
- RWJ-394718
- T-0687
- T-1095A
- SGLT-2 inhibitors (diabetes), Tanabe/Johnson & Johnson
- NKPYIZCCIFRRRC-USWKJHDZSA-N
Look up T-1095 in the interactive SynDRA portal →